Found: 6
Select item for more details and to access through your institution.
No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10741-8
- By:
- Publication type:
- Article
PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4291, doi. 10.3390/cancers13174291
- By:
- Publication type:
- Article
Tumour heterogeneity poses a significant challenge to cancer biomarker research.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 4, p. 1228, doi. 10.1002/ijc.32832
- By:
- Publication type:
- Article
DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 895, doi. 10.1038/s41416-024-02780-x
- By:
- Publication type:
- Article
Egenskaper ved kreftcellenes DNA påvirker prognosen.
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2017, v. 137, n. 19, p. 1519
- By:
- Publication type:
- Article